About this trial

The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.

Eligibility criteria

Qualifiers

Age ≥18 years;

Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.

Disqualifiers

The expected survival is less than 1 years;

Simultaneously merge other serious diseases;

Trial design

Treatments tested in this trial

  • Interventional or surgical treatment
  • Interventional or surgical treatment

Treatment groups

2,000 Participants
are divided into 5 treatment groups

Locations

1
Beijing Anzhen Hospital Beijing China

Sponsors and collaborators

Beijing Anzhen Hospital

Lead sponsor